NCT02924701View on ClinicalTrials.gov

sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis

Active, not recruitingOBSERVATIONAL
Enrollment

168

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

January 31, 2031

Study Completion Date

September 30, 2031

Conditions
Primary Biliary CirrhosisLiver Inflammation
Interventions
OTHER

Blood samples, fibroscan and questionaires

Trial Locations (1)

8000

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Denmark, Aarhus C

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT02924701 - sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis | Biotech Hunter | Biotech Hunter